Hypokalemic periodic paralysis: An autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel

Neuromuscular Disorders

Volumn 7, Issue 4, 1997, Pages 234-240

  Lapie, Pascale ^a   Lory, Philippe ^b   Fontaine, Bertrand ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

Calcium channel; DHP receptor; Electrophysiological recordings; Hypokalemic periodic paralysis; In vitro cell expression system

Indexed keywords

ARGININE; CALCIUM CHANNEL; GLYCINE; HISTIDINE; POTASSIUM;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; GENE MUTATION; HYPOKALEMIC PERIODIC PARALYSIS; MUSCLE WEAKNESS; PRIORITY JOURNAL;

ANIMALS; CALCIUM CHANNELS; GENES, DOMINANT; HUMANS; HYPOKALEMIA; ION CHANNEL GATING; MEMBRANE POTENTIALS; MUTATION; PARALYSIS; PERIODICITY;

EID: 0030992784     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(97)00435-5     Document Type: Article

References (68)

1. Rüdel R, Lehmann-Horn F, Ricker K, Küther R. Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve 1984;7:110-20.
2. Fontaine B, Khurana TS, Hoffman EP, et al. Hyperkalemic periodic paralysis and the adult muscle sodium channel α-subunit gene. Science 1990;250:1000-2.
3. Ebers GC, George AL, Barchi RL, et al. Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene. Ann Neurol 1991;30:810-6.
4. Koch MC, Ricker K, Otto M, et al. Linkage data suggesting allelic heterogeneity for paramyotonia congenita and hyperkalemic periodic paralysis on chromosome 17. Hum Genet 1991;88:71-4.
5. Ptacek LJ, George Jr AL, Griggs RC, et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991;67:1021-7.
6. Ptacek LJ, Trimmer JS, Agnew WS, Roberts JW, Petajan JH, Leppert M. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus. Am J Hum Genet 1991;49:851-4.
7. + channel α-subunit in hyperkalemic periodic paralysis. Nature 1991;354:387-9.
8. McClatchey AI, Van Den Berg P, Pericak-Vance MA, et al. Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell 1992;68:769-74.
9. McClatchey AI, McKenna-Yasek D, Cros D, et al. Novel mutations in families with unusual and variable disorders of the skeletal sodium channel. Nat Genet 1992;2:148-52.
10. Ptacek LJ, George Jr AL, Barchi RL, et al. Mutations in an S4 segment of the adult skeletal muscle sodium channel causes paramyotonia congenita. Neuron 1992;8:891-7.
11. Heine R, Pika U, Lehmann-Horn F. A novel SCN4A mutation causing myotonia aggravated by cold and potassium. Hum Mol Genet 1993;2:1349-53.
12. Ptacek LJ, Tawil R, Griggs RC, et al. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita and hyperkalemic periodic paralysis. Neurology 1994;44:1500-3.
13. Ricker K, Moxley R T, Heine R, Lehmann-Horn F. Myotonia fluctuans. A third type of muscle sodium channel disease. Arch Neurol 1994;51:1095-102.
14. Fontaine B, Vale Santos J, Jurkat-Rott K, et al. Mapping of the hypokalaemic periodic paralysis (hypoPP) locus to chromosome 1q31-1q32 in three european families. Nat Genet 1994;6:67-271.
15. Jurkat-Rott K, Lehmann-Horn F, Elbaz A, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 1994;3:1415-9.
16. Ptacek LJ, Tawil R, Griggs RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994;77:863-8.
17. Cannon C S. Ion-channel defects and aberrant excitability in myotonia and periodic paralysis. Trends Neurosci 1996;19:3-10.
18. Fontaine B, Lapie P, Plassart E, et al. Periodic paralysis and voltage-gated ion channels. Kidney Int 1996;49:9-18.
19. Hoffman EP, Lehmann-Horn F, Rüdel R. Overexcited or inactive: ion channels in muscle disease. Cell 1995;50:681-6.
20. Talbott JH. Periodic paralysis. Medicine 1941;20:85-96.
21. Holtzapple GE. Periodic paralysis. J Am Med Assoc 1905;45:1224.
22. Levitt LP, Rose LI, Dawson DM. Hypokalemic periodic paralysis with arrhythmia. N Engl J Med 1972;286:253.
23. Engel AG. Vacuolar myopathies: multiple etiologies and sequential structural studies. In: Pearson CM; Mostofi FK, eds. The Striated Muscle. Baltimore: Williams Wilkins, 1973:301.
24. Dyken M, Zeman W, Rusche T. Hypokalemic periodic paralysis. Children with permanent myopathic weakness. Neurology 1969;19:691-9.
25. Bradley WG, Taylor R, Rice DR, et al. Regressive myopathy in hyperkalemic periodic paralysis. Arch Neurol 1990;47:1013-7.
26. Engel AG. Evolution and content of vacuoles in primary hypokaliemic periodic paralysis. Mayo Clin Roc 1970;45:774-814.
27. Engel WK, Bishop DW, Cunningham GG. Tubular aggregates in type II muscle fibers: ultrastructural and histochemical correlation. J Ultrastructure Res 1970;31:507-25.
28. Casley WL, Allon M, Cousin HK, et al. Exclusion of linkage between hypokalemic periodic paralysis (Hokpp) and three candidate loci. Genomics 1992;14:493-4.
29. Fontaine B, Trofatter J, Rouleau GA, et al. Different gene loci for hyperkalemic and hypokalemic periodic paralysis. Neuromusc Disord 1991;1:235-8.
30. Weissenbach J, Gyapa G, Dib C, et al. A second-generation linkage map of the human genome. Nature 1992;359:794-801.
31. Iles DE, Segers B, Olde Weghuis D, et al. Refined localization of the α1-subunit of the skeletal muscle L-type voltage-dependent calcium channel (CACNL1A3) to human chromosome 1q32 by in situ hybridization. Genomics 1994;19:561-3.
32. 2+ channel (CACNL1A3) to chromosome 1q31-32. Genomics 1993;15:107-12.
33. Curtis BM, Catterall WA. Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules. Biochemistry 1984;23:2113-8.
34. Catterall WA. Structure and function of voltage-sensitive ion channel. Science 1988;242:50-61.
35. Perez-Reyes E, Kim HS, Lacerda AE, et al. Induction of calcium currents by the expression of the α1-subunit of the dihydropyridine receptor from skeletal muscle. Nature 1989;340:233-6.
36. Isom LL, De Jongh KS, Catterall WA. Auxiliary subunits of voltage-gated ion channels. Neuron 1994;12:1183-94.
37. Lory P, Varadi G, Schwartz A. Molecular insights into regulation of L-type Ca channel function. NIPS 1991;6:277-81.
38. 2+ channels. J Biol Chem 1992;267:1403-6.
39. Nargeot J, Dascal N, Lester HA. Heterologous expression of calcium channels. J Membrane Biol 1992;126:97-108.
40. Tanabe T, Beam KG, Powell JA, Numa S. Restoration of excitation-contraction coupling and slow calcium current in dysgenic musle by dihydropyridine receptor complementary DNA. Nature 1988;336:134-9.
41. Noda M, Shimizu S, Tanabe T, et al. Primary structure of electrophorus electricus sodium channel deduced from cDNA sequence. Nature 1984;312:121-7.
42. Guy HR, Conti F. Pursuing the structure and function of voltage-gated channels. Trends Neurosci 1990;13:201-6.
43. Catterall WA. Structure and fonction of voltage-gated ion channels. Trends Neurosci 1993;16:500-6.
44. Sipos I, Jurkat-Rott K, Harasztosi C, et al. Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes. J Physiol 1995;483:299-306.
45. Lehmann-Horn F, Sipos I, Jurkat-Rott K, et al. Altered calcium currents in human hypokalemic periodic paralysis myotubes expressing mutant L-type calcium channels. In: Ion Channels and Genetic Diseases. The Rockefeller University Press, 1995:101-13.
46. Grosson CLS, Esteban J, Mckennayasek D, Gusella JF, Brown RH. Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect. Neuromusc Disord 1996;6:27-31.
47. Elbaz A, Vale-Santos J, Jurkat-Rott K, et al. Hypokalemic periodic paralysis (hypoPP) and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1994;56:374-80.
48. Boerman RH, Ophoff RA, Links TP, et al. Mutation in DHP-receptor α1-subunit (CACNL1A3) gene in a dutch family with hypokalemic periodic paralysis. J Med Genet 1995;32:44-7.
49. Plassart E, Elbaz A, Vale-Santos J, et al. Genetic heterogeneity in hypokalemic periodic paralysis (HypoPP). Hum Genet 1994;94:551-6.
50. Tabb JS, Fanger GR, Wilson EM, Mauer RA, Henderson LP. Suppression of sodium channel function in differentiating C2 muscle cells stably overexpressing rat androgen receptors. J Neurosci 1994;14:763-73.
51. Mermelstein PG, Becker JB, Surmeier DJ. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci 1996;16:595-604.
52. Franzini-Amstrong C, Jorgensen AO. Structure and development of E-C coupling units in skeletal muscle. Annu Rev Physiol 1994;56:509-34.
53. Lapie P, Goudet C, Nargeot J, Fontaine B, Lory P. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1S subunit as expressed in mouse L cells. FEBS Lett 1996;382:244-8.
54. Lerche H, Klugbauer N, Lehmann-Horn F, Hofmann F, Melzer W. Expression and functional characterization of the cardiac L-type calcium channel carrying a skeletal muscle DHP-receptor mutation causing hypokalaemic periodic paralysis. Pflugers Arch (Eur J Physiol) 1996;431:461-3.
55. Varadi G, Lory P, Schultz D, Varadi M, Schwartz A. Acceleration of activation and inactivation by the β subunit of the skeletal muscle calcium channel. Nature 1991;352:159-62.
56. Hogan K, Powers PA, Gregg RG. Cloning of the human skeletal α1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics 1994;24:608-9.
57. Tanabe T, Takeshima H, Mikami A, et al. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 1987;328:313-8.
58. Ellis SB, Williams ME, Ways NR, et al. Sequence and expression of mRNAs encoding the α1 and α2 subunits of a DHP-sensitive calcium channel. Science 1988;241:1661-4.
59. Chahine M, George ALJ, Zhou M, et al. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation. Neuron 1994;12:281-94.
60. Sorrentino V. The ryanodine receptor family of intracellular calcium release channels. Adv Pharmacol 1995;33:67-90.
61. Adams BA, Beam KG. Muscular dysgenesis in mice: a model system for studying excitation-contraction coupling. FASEB J 1990;4:2809-16.
62. Takeshima H, Iino M, Takekura H, et al. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 1994;369:556-9.
63. Takekura H, Nishi M, Noda T, Takeshima H, Franzini-Armstrong C. Abnormal junctions between surface membrane and sarcoplasmic reticulum in skeletal muscle with a mutation targeted to the ryanodine receptor. Proc Natl Acad Sci USA 1995;92:3381-5.
64. Nakai J, Dirksen RT, Nguyen HT, Pessah IN, Beam KG, Allen PD. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 1996;380:72-5.
65. Chaudhari N. Muscular dysgenesis. The role of calcium channels in muscle development. In: Ion Channels and Genetic Diseases. The Rockefeller University Press, 1995:115-23.
66. Chaudhari N. A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice. J Biol Chem 1992;267:25636-9.
67. 2+ channel in dysgenic myotubes. FEBS Lett 1994;342:129-34.
68. Seigneurin-Venin S, Parrish E, Marty I, et al. Involvement of the dihydropyridine receptor and internal Ca2 + stores in myoblast fusion. Exp Cell Res 1996;223:301-7.